<- Go Home

Gyroscope Therapeutics Holdings PLC

As of February 18, 2022, operates as a subsidiary of Novartis AG.

Market Cap

N/A

Volume

N/A

Cash and Equivalents

$58.6M

EBITDA

-$86.6M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$489.2K

Profit Margin

87.20%

52 Week High

N/A

52 Week Low

N/A

Dividend

N/A

Price / Book Value

N/A

Price / Earnings

N/A

Price / Tangible Book Value

N/A

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$89.0M

Return on Equity

298.41%

Return on Assets

-93.58

Cash and Short Term Investments

$58.6M

Debt

N/A

Equity

$56.7M

Revenue

$561.0K

Unlevered FCF

-$40.4M

Sector

Biotechnology

Category

N/A

Company Stock Pitches